Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
- PMID: 33484647
- PMCID: PMC7817473
- DOI: 10.1016/S1473-3099(20)30990-7
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
Erratum in
-
Correction to Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-7.Lancet Infect Dis. 2021 Apr;21(4):e81. doi: 10.1016/S1473-3099(21)00096-7. Epub 2021 Feb 15. Lancet Infect Dis. 2021. PMID: 33600758 Free PMC article. No abstract available.
Comment on
-
What reinfections mean for COVID-19.Lancet Infect Dis. 2021 Jan;21(1):3-5. doi: 10.1016/S1473-3099(20)30783-0. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058796 Free PMC article. No abstract available.
-
A case of SARS-CoV-2 reinfection in Ecuador.Lancet Infect Dis. 2021 Jun;21(6):e142. doi: 10.1016/S1473-3099(20)30910-5. Epub 2020 Nov 23. Lancet Infect Dis. 2021. PMID: 33242475 Free PMC article. No abstract available.
References
-
- Baumjohann D, Preite S, Reboldi A, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2020;38:596–605. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous